Where Senior CDMO Commercial Talent Actually Sits: How to Access It

A senior commercial search opens at a CDMO, and the shortlist almost always starts in the same place: big pharma. A BD director or VP with a decade at a name everyone in the room already trusts. It reads like the safe choice. Six months in, it often isn't working, and the reason rarely comes down to ability.

‍

Why the obvious hire often isn't the right one

The mismatch sits in what the two careers actually teach. A commercial career inside big pharma is built around managing an established brand, launching into a market where the infrastructure already exists, and working inside a large internal machine where a dozen adjacent functions handle the groundwork before commercial gets involved. Commercial work inside a CDMO looks different from the first conversation. Before a sponsor will discuss price or timeline, the person in front of them needs to be credible on capability: GMP readiness, technology transfer, the practical mechanics of scaling a process from lab to line. Business development at a CDMO is closer to a technical sale than a brand one, and it's consistently one of the hardest roles in life sciences to fill well, because scientific credibility, manufacturing understanding and established sponsor relationships rarely sit inside the same CV.

Hire on the logo alone and you've usually bought a bet on someone learning an entirely different discipline from scratch, in public, in front of the sponsors whose trust the role depends on.

‍

Where senior CDMO commercial talent actually comes from

Some of the strongest fits for a CDMO commercial role are already sitting on the sponsor side, in outsourcing, external manufacturing or CMC management roles inside pharma and biotech companies. These are people who've spent years sat across the table from CDMOs, running the RFPs, sitting through the technical reviews, and forming a clear view of what actually makes a partner trustworthy versus what just sounds good in a pitch. Once they understand the move is possible, a fair number are genuinely open to it. Most CDMO searches never look here, because the brief is written around commercial job titles, and these people don't carry one yet.

A second pool sits inside process development, MSAT and technology transfer teams, people who've ended up doing commercial work without the title catching up. Sponsors trust them in the early, technical stage of a relationship long before procurement or commercial formally gets involved, and some of them are already the reason deals close. A keyword search built around "business development" or "commercial director" will miss every one of them.

A third group is defined less by function than by what they've actually done: built a commercial function from very little at a smaller or growth-stage CDMO, rather than stepped into one that already existed at scale. Running an established commercial team at a large platform and standing one up with limited infrastructure and no established sponsor base are different skills, and the second is rarer and harder to spot from a job title alone.

A fourth pool sits outside pharma entirely, in adjacent regulated manufacturing sectors such as specialty chemicals, fine ingredients and contract analytical or testing businesses. The underlying skill, selling technical trust in a regulated, capacity-constrained environment, already exists there. It just isn't labelled in pharma terms, so it rarely surfaces in a pharma-specific search.

‍

Why this talent barely shows up in a search

None of these four groups look like an obvious CDMO commercial candidate on paper. Most aren't job hunting. They're doing well where they are, and in a market this consolidated, they're often the person a competitor is quietly trying to poach rather than someone signalling availability. The technical-to-commercial pivots don't have "commercial" anywhere in their title, so keyword search misses them by design. The sponsor-side switch is one most of them haven't seriously considered until someone lays out what the move would actually involve.

That's also why generic outreach tends to fail here. A message built around an "exciting opportunity" lands on someone who already has a good role and has probably had several similar messages that month. It gives them no reason to engage with a pitch that doesn't show any understanding of what they'd be moving into.

‍

How to actually access this talent

Finding people in these pools takes a market map built over years of conversations across the sector, not a fresh search assembled every time a role opens. It also takes a different kind of conversation. Someone who has sat inside a CDMO commercial build themselves, not just recruited around the edges of one, can talk to a sponsor-side CMC lead or a technical-to-commercial candidate about what the move genuinely involves: the pace, the reporting lines, what building trust with a portfolio of sponsors looks like day to day. That's a different conversation from a generic sell, and it's usually the difference between someone taking the call and someone ignoring it.

It's part of why our approach to CDMO recruitment at Vector stays close to people who've actually built these functions rather than just placed people into them. Our founders built a CDMO themselves before founding Vector, and that background changes the kind of conversation we can have with a passive commercial candidate. We're not asking them to trust a pitch. We're asking them to trust that we understand exactly what they'd be walking into.

The businesses that get commercial hiring right in this sector tend to treat it as its own discipline, distinct from general executive search, and built around where this talent actually sits rather than where it's easiest to find. That is the shift most CDMO commercial searches still need to make.

‍

Building or rethinking a commercial function inside a CDMO?

I work exclusively across CDMO M&A and commercial talent, and can help you map where the right hire is genuinely likely to come from.